Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Thomas Lönngren | M | 73 | 3 ans | |
| Mats Blom | M | 59 | 3 ans | |
| Nicklas Westerholm | M | 48 | 7 ans | |
| Lena Elisabeth Svanberg | M | 63 | 7 ans | |
| Peder Sven Walberg | M | 50 | 4 ans | |
| Yilmaz Mahshid | M | 45 | 3 ans | |
| Karl Hård | M | 62 | 2 ans | |
| Gunilla Christina Osswald | M | 63 | 7 ans | |
| Peter Verwaijen | M | - | 2 ans | |
| Marianne Berrens-Peijnenburg | M | - | 2 ans | |
| Anna Sjögren | F | 56 | - | |
| Kristina Nygren | - | - | 3 ans | |
| Christian Sonesson | M | 49 | 7 ans | |
| Henrik Krook | M | 51 | 4 ans | |
| Malin Nittve | F | 61 | - | |
| Katayoun Welin-Berger | M | 56 | 1 ans | |
| Marie Bengtson | F | - | 13 ans | |
| Mark Altmeyer | M | 63 |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | 3 ans |
| Nils Hallén | M | 56 | 1 ans |
Voir plus
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Suède | 18 | 94,74% |
| Pays-Bas | 1 | 5,26% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Laetitia Szaller
- Réseau Personnel
